VCP
EXAS

Verus Capital Partners’s Exact Sciences EXAS Stock Holding History

Verus Capital Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$40K Buy
691
+200
+41% +$16.2K 0.01% 559
2019
Q4 		$45K Buy
+491
New +$43.2K 0.01% 630

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Verus Capital Partners's EXAS Position: Q1 2020 in Review

Verus Capital Partners increased its Exact Sciences (EXAS) stake by 41% in Q1 2020, buying an estimated $16.2K and bringing the position to 691 shares worth $40K. The position accounts for 0.01% of the portfolio, ranked #559.

Verus Capital Partners first reported a position in EXAS in Q4 2019 and has held it in 2 quarters since. The position peaked at $45K in Q4 2019. 476 funds tracked by Wall St. Rank hold EXAS as of Q1 2020.

  • Verus Capital Partners held 691 shares of Exact Sciences worth $40K as of Q1 2020.
  • Verus Capital Partners bought 200 Exact Sciences shares in Q1 2020, an estimated $16.2K.
  • Exact Sciences made up 0.01% of Verus Capital Partners's portfolio in Q1 2020, its #559 holding.
  • Verus Capital Partners first reported a position in Exact Sciences in Q4 2019 and has held it in 2 quarters since.
  • Verus Capital Partners's Exact Sciences position peaked at $45K in Q4 2019.
  • 476 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.